Purchase Order 75F40119P10391
- Not listed
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a delivery order contract on July 31, 2018, for the service and delivery of 7,500 fast real-time PCR (polymerase chain reaction) systems. The contract, valued at $4,470.03 and designated as firm fixed price, was issued without a set-aside designation, reflecting the contractor's competitive standing in federal procurement. The place of performance is located in St. Paul, Minnesota, with an ultimate...
- This federal contract award is for REAL TIME PCR ACCESSORIES valued at $20,923.80. The contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Life Technologies Corporation, doing business as Thermo Fisher Scientific. Life Technologies is a prominent manufacturer of scientific instruments, reagents, and consumables that provides specialized biotechnology products and services to federal agencies. The contract is a firm fixed price purchase order...
- The U.S. government awarded a delivery order contract valued at $4,014.60 to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on September 7, 2017, for a Fast Real Time PCR System Service Contract. The contract, which operated under a Firm Fixed Price structure with no set-aside designation, was funded by a civilian federal agency and completed by September 29, 2018. The work was performed in Carlsbad, California, where Thermo Fisher maintains significant...
- The Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $37,145.96 to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on August 15, 2023, for a QuantStudio 7 Flex real-time polymerase chain reaction (qPCR) system with preventative maintenance and unlimited repairs service agreement. The contract covers a base period with two option years, with an ultimate completion date of August 14, 2026. The contract was awarded without set-aside...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is valued at $153,142.00 and runs through June 6, 2027. The contract is for Life Technologies to perform molecular analyses of bacteria isolated from regulatory samples using the ABI7500 Fast Real-Time PCR system. This specialized laboratory equipment is critical for the FDA's Office of Regulatory Affairs...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a firm fixed-price purchase order valued at $4,470.04 by a civilian federal agency in the Midwest Area on August 11, 2018. The contract covers a service agreement for 7500 FAST Real Time PCR equipment (Serial #25014510), with an ultimate completion date of August 28, 2019. The place of performance is Carlsbad, California. No set-aside designation was used in this award. Life Technologies Corporation is a...
- The U.S. Food and Drug Administration (FDA) awarded a $76,772.10 firm fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for an ABI 7500 Fast Real-Time PCR Instrument. This sole-source award was made under FAR 6.302-1, FAR 13.106(b), and FAR 5.203, as the FDA determined that only Life Technologies could provide the required system. The award does not have a set-aside designation. As a manufacturer of scientific instruments, reagents, and...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $27,395.63 firm fixed-price delivery order for a real-time PCR thermocycler on September 23, 2019, with an ultimate completion date of September 21, 2020. The contract, which carries no set-aside designation, was funded by a civilian federal agency and calls for performance in Carlsbad, California. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation and serves as a leading supplier...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a delivery order contract on July 8, 2017, for a service agreement related to a 7500 Fast Real Time PCR System (Serial #275000646). This firm fixed-price delivery order, valued at $4,877.28, was funded by a civilian federal agency and is set to be completed by September 21, 2020. The contract will be performed at the company's facility in Carlsbad, California. As a leading manufacturer of scientific...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $4,877.28 firm fixed price purchase order by a civilian federal agency (Midwest Area) on August 2, 2017, for service agreement on a 7500 FAST Real Time PCR System. The contract, which was not set aside for small businesses, is scheduled for completion by July 31, 2018, with performance taking place in West Lafayette, Indiana. This award represents a routine procurement of maintenance or support services...
The Food and Drug Administration awarded a $15,682.41 firm fixed-price purchase order to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on July 15, 2019, for a Fast Real Time PCR Systems Service Agreement. The contract, with an ultimate completion date of August 14, 2020, was performed in Carlsbad, California, and involved no set-aside designation. Life Technologies Corporation, a leading manufacturer of scientific instruments and biotechnology products, supplies specialized laboratory equipment including real-time PCR systems and related services to numerous federal agencies supporting research, diagnostic, and analytical initiatives. Life Technologies Corporation operates as a subsidiary of Thermo Electron Corporation, a major provider of analytical instrumentation and equipment to the federal government. Thermo Electron maintains a $9.5 million blanket purchase agreement with the FDA under the GSA Multiple Award Schedule program for advanced analytical equipment, providing context for the broader procurement relationship between these entities and the agency. The service agreement represents a targeted procurement for real-time PCR system support, aligning with the FDA's laboratory and regulatory testing capabilities in areas such as food safety, pharmaceutical analysis, and public health surveillance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 7/15/19 |